Happy Thursday, folks!

As interest grows in Alzheimer’s prevention and precision medicine, Anne O. Rice, RDH, CDP, FAAOSH, argues for caution, especially around APOE genotyping and blood-based p-Tau assays, which require careful counseling, interpretation, privacy safeguards, and referral pathways.

It also raises a practical question: Could dentistry make a greater impact on brain health by strengthening the screenings and preventive tools already within reach?